Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.

Deane, K H O; Spieker, S; Clarke, C E

Deane, K H O; Spieker, S; Clarke, C E.

Cochrane Database Syst Rev ; (4): CD004554, 2004 Oct 18.

Article in En | MEDLINE | ID: mdl-15495119

Subject(s)

Antiparkinson Agents/therapeutic use; Benzophenones/therapeutic use; Catechol O-Methyltransferase Inhibitors; Catechols/therapeutic use; Enzyme Inhibitors/therapeutic use; Nitrophenols/therapeutic use; Parkinson Disease/drug therapy; Antiparkinson Agents/adverse effects; Humans; Levodopa/adverse effects; Nitriles; Tolcapone

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Benzophenones / Catechols / Enzyme Inhibitors / Catechol O-Methyltransferase Inhibitors / Nitrophenols / Antiparkinson Agents Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Cochrane Database Syst Rev Journal subject: PESQUISA EM SERVICOS DE SAUDE Year: 2004 Type: Article

Fulltext

XML

PubMed Links

Search on Google